Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to share that temperature-controlled packaging suppliers Cold Chain Technologies and Almac Clinical Services were recently announced as winners of the “Global Forum Excellence Awards for Best Innovative Supply Chain Strategy” and “Best Supplier Collaboration” at the 16th Annual Cold Chain Global Forum in Philadelphia, PA.
The selection of these companies was based on developing and implementing the Almac Pod™ Program: an innovative reusable small parcel temperature-controlled shipper and accompanying qualified refurbishment program. With Almac’s help, the companies co-created a high-performing shipping solution managed by a robust and repeatable refurbishment process, resulting in a program that has enabled increased throughput, improved program costs, enhanced temperature protection duration, weight reductions and reduced waste.
Leon Supplee, Director of Logistics, commented, “I am delighted to accept these awards on behalf of Almac Clinical Services and in conjunction with Cold Chain Technologies. The Almac Pod™ Program resulted from close and continuing collaboration between our organizations and we are very pleased with the outcome and ongoing benefits.”
“We are very pleased to receive these awards at the Cold Chain Global Forum. This represents important recognition among our peers of the value and effectiveness of the Almac Pod™ Program, as well as how this reusable shipping solution and refurbishment program results in real operational benefits to organizations like Almac Clinical Services,” said Anthony Rizzo, Senior Vice President at Cold Chain Technologies.
Cold Chain Technologies is a leading global provider of single-use and reusable thermal packaging solutions for the distribution and transport of temperature-sensitive shipments. The company is ISO 9001:2015 registered, with over 50 years of ensuring product safety for the pharmaceutical, life science, and food service industries.
About Almac Group
A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Our innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia. Click here to view our facilities.
We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.